These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Caregivers' perception of patients' cognitive deficit in schizophrenia and its influence on their quality of life. Caqueo-Urízar A; Urzúa A; Boyer L Psicothema; 2016 May; 28(2):150-5. PubMed ID: 27112811 [TBL] [Abstract][Full Text] [Related]
43. Aberrant intrinsic brain activity and cognitive deficit in first-episode treatment-naive patients with schizophrenia. He Z; Deng W; Li M; Chen Z; Jiang L; Wang Q; Huang C; Collier DA; Gong Q; Ma X; Zhang N; Li T Psychol Med; 2013 Apr; 43(4):769-80. PubMed ID: 22883428 [TBL] [Abstract][Full Text] [Related]
45. The relationship between visual-perception and attention in Chinese with schizophrenia. Lee TM; Cheung PP Schizophr Res; 2005 Jan; 72(2-3):185-93. PubMed ID: 15560963 [TBL] [Abstract][Full Text] [Related]
46. The crucial role of sustained attention in community functioning in outpatients with schizophrenia. Prouteau A; Verdoux H; Briand C; Lesage A; Lalonde P; Nicole L; Reinharz D; Stip E Psychiatry Res; 2004 Dec; 129(2):171-7. PubMed ID: 15590044 [TBL] [Abstract][Full Text] [Related]
47. Cognitive Deficits in Patients With Neuropsychiatric Symptoms: A Comparative Study Between Behavioral Variant Frontotemporal Dementia and Primary Psychiatric Disorders. Vijverberg EGB; Schouws S; Meesters PD; Verwijk E; Comijs H; Koene T; Schreuder C; Beekman A; Scheltens P; Stek M; Pijnenburg Y; Dols A J Clin Psychiatry; 2017; 78(8):e940-e946. PubMed ID: 28749089 [TBL] [Abstract][Full Text] [Related]
49. The reliability and clinical correlates of figure-ground perception in schizophrenia. Malaspina D; Simon N; Goetz RR; Corcoran C; Coleman E; Printz D; Mujica-Parodi L; Wolitzky R J Neuropsychiatry Clin Neurosci; 2004; 16(3):277-83. PubMed ID: 15377734 [TBL] [Abstract][Full Text] [Related]
50. Gaze control during face exploration in schizophrenia. Delerue C; Laprévote V; Verfaillie K; Boucart M Neurosci Lett; 2010 Oct; 482(3):245-9. PubMed ID: 20667499 [TBL] [Abstract][Full Text] [Related]
51. Correlation between neurocognitive impairment and DNA methylation of MMP-9 gene in patients with deficit schizophrenia. Gao J; Tang X; Kang J; Xie C; Yu M; Sha W; Wang X; Zhang X; Zhang X; Yi H Schizophr Res; 2019 Feb; 204():455-457. PubMed ID: 30337154 [No Abstract] [Full Text] [Related]
52. Neural correlates of visuo-spatial attention during an antisaccade task in schizophrenia: an ERP study. Tendolkar I; Ruhrmann S; Brockhaus-Dumke A; Pauli M; Mueller R; Pukrop R; Klosterkötter J Int J Neurosci; 2005 May; 115(5):681-98. PubMed ID: 15823932 [TBL] [Abstract][Full Text] [Related]
53. Attention shaping as a means to improve emotion perception deficits in outpatients with schizophrenia and impaired controls. Combs DR; Chapman D; Waguspack J; Basso MR; Penn DL Schizophr Res; 2011 Apr; 127(1-3):151-6. PubMed ID: 20570490 [TBL] [Abstract][Full Text] [Related]
54. Neuropsychological correlates of remission in chronic schizophrenia subjects: The role of general and task-specific executive processes. Rabanea-Souza T; Akiba HT; Berberian AA; Bressan RA; Dias ÁM; Lacerda ALT Schizophr Res Cogn; 2016 Mar; 3():39-46. PubMed ID: 28740806 [TBL] [Abstract][Full Text] [Related]
55. Evidence that polygenic risk for psychotic disorder is expressed in the domain of neurodevelopment, emotion regulation and attribution of salience. van Os J; van der Steen Y; Islam MA; Gülöksüz S; Rutten BP; Simons CJ; Psychol Med; 2017 Oct; 47(14):2421-2437. PubMed ID: 28436345 [TBL] [Abstract][Full Text] [Related]
56. Neurocognitive deficits or stress overload: Why do individuals with schizophrenia show poor performance in neurocognitive tests? Krkovic K; Moritz S; Lincoln TM Schizophr Res; 2017 May; 183():151-156. PubMed ID: 27838097 [TBL] [Abstract][Full Text] [Related]
57. The associations between multisensory temporal processing and symptoms of schizophrenia. Stevenson RA; Park S; Cochran C; McIntosh LG; Noel JP; Barense MD; Ferber S; Wallace MT Schizophr Res; 2017 Jan; 179():97-103. PubMed ID: 27746052 [TBL] [Abstract][Full Text] [Related]
58. Neurocognitive insight, treatment utilization, and cognitive training outcomes in schizophrenia. Burton CZ; Twamley EW Schizophr Res; 2015 Feb; 161(2-3):399-402. PubMed ID: 25534069 [TBL] [Abstract][Full Text] [Related]
59. Relationship between metabolic syndrome and cognition in patients with schizophrenia. Lindenmayer JP; Khan A; Kaushik S; Thanju A; Praveen R; Hoffman L; Cherath L; Valdez G; Wance D Schizophr Res; 2012 Dec; 142(1-3):171-6. PubMed ID: 23106932 [TBL] [Abstract][Full Text] [Related]
60. Sensory integration deficits support a dimensional view of psychosis and are not limited to schizophrenia. Carter O; Bennett D; Nash T; Arnold S; Brown L; Cai RY; Allan Z; Dluzniak A; McAnally K; Burr D; Sundram S Transl Psychiatry; 2017 May; 7(5):e1118. PubMed ID: 28485725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]